Congress

14:00 - 14:20
A Visão da CONITEC

BRUNO BARROS

RIO DE JANEIRO / RJ Palestrante

14:20 - 14:25
Discussão

14:25 - 14:45
Acesso ao Tratamento de Doenças Raras no Brasil

FERNANDO RAMIREZ

SAO PAULO / SP Palestrante

14:45 - 14:50
Discussão

14:50 - 15:10
O Direito do Paciente no Brasil

SUMAYA AFIF

SAO PAULO / SP Speaker

15:10 - 15:15
Discussão

15:15 - 15:35
A Visão do Médico Especialista

BIANCA ETELVINA SANTOS DE OLIVEIRA

JOAO PESSOA / PB Speaker

15:35 - 15:40
Discussão

16:10 - 16:30
Autoimmune encephalitis in children

LIVIA DUTRA

SAO PAULO / SP Speaker

16:30 - 16:35
Discussion

16:35 - 16:55
NMOSD in children - Update in Treatment and Neuroimaging

RENATA PAOLILO

SAO PAULO / SP Speaker

16:55 - 17:00
Discussion

17:00 - 17:20
Timing of high-efficacy therapies for pediatric patients with multiple sclerosis

SILVIA TENEMBAUM

Speaker

17:20 - 17:25
Discussion

17:25 - 17:45
How safe are MS drugs in children?

MANUELA FRAGOMENI

BRASILIA / DF Speaker

17:45 - 17:50
Discussion

19:00 - 19:30
Time Vencedor 2022

RAFAEL PATERNO CASTELLO DIAS CARNEIRO

SAO PAULO / SP Competitor

SIMONE ABRANTE LUCATTO

VILHENA / RO Competitor

LAURA PAROLIN

JOINVILLE / SC Competitor

JOAO MARCOS CAMPOS FERREIRA

NITEROI / RJ Competitor

BRUNA KLEIN DA COSTA

PORTO ALEGRE / RS Competitor

VINICIUS DE OLIVEIRA BOLDRINI

CAMPINAS / SP Competitor

KENIA REPISO CAMPANHOLO

SALVADOR / BA Competitor

19:30 - 20:00
Time Desafiante 2023

MATEUS BOAVENTURA DE OLIVEIRA

SAO PAULO / SP Competitor

LAIS MARIA BRITO

SALVADOR / BA Competitor

NATHANE BRAGA

RIO DE JANEIRO / RJ Competitor

CAIO DISSEROL

CURITIBA / PR Competitor

MANUELA FRAGOMENI

BRASILIA / DF Competitor

PAULO LISBOA

FORTALEZA / CE Competitor

LARISSA ARAUJO DUARTE

RIO DE JANEIRO / RJ Competitor

08:00 - 08:20
New diagnostic criteria for MOGAD

DOUGLAS KAZUTOSHI SATO

PORTO ALEGRE / RS Speaker

08:20 - 08:25
Discussion

08:25 - 08:45
The role of the choroid plexuses in MS: Neuroimaging contribution

BRUNO STANKOFF

Speaker

08:45 - 08:50
Discussion

08:50 - 09:10
Tuberculosis in multiple sclerosis patients

CARLOS NAVAS

Presenter

09:10 - 09:15
Discussion

09:15 - 09:35
Disease Characteristics of Latinx patients using quantitative multi-center data approaches

DANIEL ONTANEDA

Speaker

09:35 - 09:40
Discussion

09:40 - 10:00
Environmental risk factors for MS

MOHAMMAD ALI SAHRAIAN

Speaker

10:00 - 10:05
Discussion

10:05 - 10:25
Pathophysiology of NMOSD revisited

KAZUO FUJIHARA

Speaker

10:25 - 10:30
Discussion

11:15 - 12:00
Gaps in the understanding of MS etiopathogenesis

ALBERTO ASCHERIO

Speaker

13:00 - 13:30
High-efficacy treatment early: challenging the status quo

GUTEMBERG SANTOS

RIO DE JANEIRO / RJ Speaker

13:30 - 14:00
Experience: the benefit-risk profile of ofatumumab

ROBERT SHIN

Speaker

14:00 - 14:20
Deep grey matter injury in multiple sclerosis

DANIEL ONTANEDA

Speaker

14:20 - 14:25
Discussion

14:25 - 14:45
New Trends in MS: Remyelination

GIORDANI RODRIGUES DOS PASSOS

PORTO ALEGRE / RS Speaker

14:45 - 14:50
Discussion

14:50 - 15:10
Will EBV infection prevention be enough to prevent MS?

ALBERTO ASCHERIO

Speaker

15:10 - 15:15
Discussion

15:15 - 15:25
Platform presentation 1 - Reliability of telemedicine evaluation for EDSS functional systems in multiple sclerosis. - Presenter: Cássia Elisa Marin

15:25 - 15:30
Discussion

15:30 - 15:40
Platform presentation 2 - Plasma Neurofilament Light Chain in relapsing remitting multiple sclerosis patients: a new NEDA parameter? - Presenter: Larissa Araujo Duarte

15:40 - 15:45
Discussion

16:15 - 16:35
Markers of disease progression in MS

GIANCARLO COMI

Speaker

16:35 - 16:40
Discussion

16:40 - 17:00
How does MS affect aging?

JORGE CORREALE

Speaker

17:00 - 17:05
Discussion

17:05 - 17:25
MS treatment dilemma: High efficacy therapies from onset or escalation therapy?

JEFFERSON BECKER

PORTO ALEGRE / RS Speaker

17:25 - 17:30
Discussion

17:30 - 17:40
Platform presentation 3 - Cost comparison between early intensive and escalating strategies for multiple sclerosis in Brazil - Presenter: Leonardo Zumerkorn Pipek

17:40 - 17:45
Discussion

17:45 - 17:55
Platform presentation 4 - REal-world effectiveness and safety of nataLIzumab in relApsing-remittiNg multiple sClerosis Brazilian patiEnts – RELIANCE study - Presenter: Maria Fernanda Mendes

17:55 - 18:00
Discussion

19:00 - 19:10
Increased production of anti-inflammatory molecules by a B cell subset of Multiple Sclerosis patients treated with Natalizumab - Presenter: Amanda Dias da Rocha Lima

19:10 - 19:20
Senescent-like phenotype of CD8+ T lymphocytes during AQP4-positive NMOSD treated with Rituximab: Reassessing the similarity between NMOSD and MS? - Presenter: Vinícius Oliveira Boldrini

19:20 - 19:30
Leber's Optic Neuropathy and Differential Diagnosis of Atypical Optic Neuritis - Presenter: Karoline Miari Scalioni Cohen

19:30 - 19:40
IS THE MODIFIED FATIGUE IMPACT SCALE APPLIED BY TELEPHONE IN INDIVIDUALS WITH MULTIPLE SCLEROSIS VALID AND RELIABLE? An investigation of measurement properties - Presenter: Juliana Machado Santos Santiago-Amaral

19:40 - 19:50
Real-world application of 2022 diagnosis criteria and proposed classification of optic neuritis - Presenter: Sara Terrim

19:50 - 20:00
Frequency of latent tuberculosis in patients with multiple sclerosis screened for the prescription of alemtuzumab - Presenter: Flavio Vieira Marques Filho

08:00 - 10:00
Discussion

BRUNO STANKOFF

Debater

GIANCARLO COMI

Debater

KAZUO FUJIHARA

Debater

JORGE CORREALE

Debater

10:30 - 10:50
Pathophysiological mechanisms of progression

HANS-PETER HARTUNG

Speaker

10:50 - 10:55
Discussion

10:55 - 11:15
A critical view of silent progression

GIANCARLO COMI

Speaker

11:15 - 11:20
Discussion

11:20 - 11:40
Functional assessment of progression

LETIZIA LEOCANI

Speaker

11:40 - 11:45
Discussion

11:45 - 12:05
Role of brain MRI

NICOLA DE STEFANO

Speaker

12:05 - 12:10
Discussion

12:10 - 12:30
The role of PET in monitoring progressive MS

BRUNO STANKOFF

Speaker

12:30 - 12:35
Discussion

14:35 - 14:55
What are the present trends in NMOSD research?

KAZUO FUJIHARA

Speaker

14:55 - 15:00
Discussion

15:00 - 15:20
Treating MOGAD: recent past, present and future

MARCELO MATIELLO

Speaker

15:20 - 15:25
Discussion

15:25 - 15:45
How specific is NMOSD-optic neuritis?

15:25 - 15:45
How specific are MRI signs in the differential diagnosis between MS, NMOSD, and MOGAD?

CAROLINA DE MEDEIROS RIMKUS

SAO PAULO / SP Speaker

15:45 - 16:15
Discussion

16:15 - 16:25
Platform presentation 5 - MOG-IgA characterizes a subgroup of patients with central nervous system demyelination - Presenter: Ana Beatriz Ayroza Galvão Ribeiro

16:25 - 16:30
Discussion

16:30 - 16:40
Platform presentation 6 - Inebilizumab Reduces Attack Risk Independent of Low Affinity IgG Fc Region Receptor III-A Gene Polymorphisms in Neuromyelitis Optica Spectrum Disorder - Presenter: Mariana Graf

16:40 - 16:45
Discussion

17:15 - 17:35
Biomarkers of severity in NMOSD

DOUGLAS KAZUTOSHI SATO

PORTO ALEGRE / RS Speaker

17:35 - 17:40
Discussion

17:40 - 18:00
Are VEPs and OCT helpful to predict outcome in MS, NMOSD and MOGAD?

LETIZIA LEOCANI

Speaker

18:00 - 18:05
Discussion

18:05 - 18:25
Pregnancy in NMOSD

MOHAMMAD ALI SAHRAIAN

Speaker

18:25 - 18:30
Discussion

18:30 - 18:40
Platform presentation 7 - NMOSD leads to unemployment in high educational level people with NMOSD (pwNMOSD): results of an online survey with 146 NMOSD patients. - Presenter: Raquel Vassão Araujo

18:40 - 18:45
Discussion

18:45 - 18:55
Platform presentation 8 - Silent Progressive Brain Atrophy in Clinically Stable Neuromyelitis Optica A Comparative Proof-of-Concept Study - Presenter: Gustavo Medeiros Andrade Figueira

18:55 - 19:00
Discussion

08:00 - 08:25
Risk and treatment of Vitamin D deficiency in people living with MS

ALBERTO ASCHERIO

Speaker

08:25 - 08:30
Discussion

08:30 - 08:55
The spectrum of NMO and MOGAD: lessons I learned

MARCELO MATIELLO

Speaker

08:55 - 09:00
Discussion

09:00 - 09:15
 Clinical Pearls in MS differential diagnosis

MATEUS BOAVENTURA DE OLIVEIRA

SAO PAULO / SP Speaker

09:15 - 09:20
Discussion

09:20 - 09:35
Differential diagnosis for NMO

JULIANA MACHADO SANTIAGO SANTOS AMARAL

BELO HORIZONTE / MG Speaker

09:35 - 09:40
Discussion

10:40 - 11:00
Central vein sign, iron rim and Optic nerve lesions in the diagnostics and prognostic of multiple sclerosis

DOUGLAS MENDES NUNES

SAO PAULO / SP Speaker

11:00 - 11:05
Discussion

11:05 - 11:25
Smouldering lesions in MS

DANIEL ONTANEDA

Speaker

11:25 - 11:30
Discussion

11:30 - 11:50
Periventricular gradient in multiple sclerosis

BRUNO STANKOFF

Speaker

11:50 - 11:55
Discussion

11:55 - 12:15
Differential radiological diagnosis of longitudinally extensive transverse myelopathies

FERNANDA CRISTINA RUEDA LOPES

RIO DE JANEIRO / RJ Speaker

12:15 - 12:20
Discussion

12:20 - 12:40
Correlating clinical data and imaging to diagnosis multiple sclerosis

DOUGLAS MENDES NUNES

SAO PAULO / SP Speaker

12:40 - 12:45
Discussion

12:45 - 13:05
Follow-up in demyelinating diseases of the CNS: What`s the best shot?

FERNANDO FARIA ANDRADE FIGUEIRA

RIO DE JANEIRO / RJ Speaker

13:05 - 13:10
Discussion

14:00 - 14:20
Unidades de Tratamento de Esclerose Múltipla: conhecendo esse conceito

JOSE ARTUR COSTA D'ALMEIDA

EUSEBIO / CE Palestrante

14:20 - 14:40
A Equipe Multi e os Critérios atuais para o diagnóstico da Esclerose Múltipla

FERNANDO FARIA ANDRADE FIGUEIRA

RIO DE JANEIRO / RJ Palestrante

14:40 - 15:00
O que são NMOSD e MOGAD e qual sua relação com EM?

MONICA PAROLIN

CURITIBA / PR Palestrante

15:00 - 15:20
O que a equipe multiprofissional precisa saber sobre o tratamento medicamentoso da EM?

MARIA FERNANDA MENDES

SAO PAULO / SP Palestrante

15:20 - 15:40
Discussão

16:00 - 16:20
Quando o comprometimento cognitivo desafia o atendimento de enfermagem

IVONE REGINA FERNANDES

SAO PAULO / SP Palestrante

16:20 - 16:40
Avaliação Nutricional em pessoas com EM

MARIA LUISA PEREIRA DE MELO

FORTALEZA / CE Palestrante

16:40 - 17:00
Abordagem fisioterapêutica em pessoas com EM

KEYLA REJANE FRUTUOSO DE MORAIS

FORTALEZA / CE Palestrante

17:00 - 17:20
Abordagem multiprofissional de pacientes com EM: foco em estilo de vida

JULIANA MACHADO SANTIAGO SANTOS AMARAL

BELO HORIZONTE / MG Palestrante

17:20 - 17:40
Discussão